Now in its sixth year, the comprehensive study seeks to understand commercial and regulatory trends, as well as systems investment by medtech companies across revenue life cycle. It will assess shifting markets, customer and channel dynamics, the influence of reimbursement and regulatory changes, and sales and marketing responses on pricing, contracting, market access strategies, financial impact modeling, and planning.

Readers are invited to participate in this survey and MX will publish data as results become available. 

http://2010MedtechRMSurvey.questionpro.com